Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
Gilead Sciences (GILD) PT Lowered to $87 at RBC Capital
October 26, 2018 7:24 AM EDTRBC Capital analyst Brian Abrahams lowered the price target on Gilead Sciences (NASDAQ: GILD) to $87.00 (from $89.00) while maintaining a Outperform rating.
... MoreGilead Sciences (GILD) Declares $0.57 Quarterly Dividend; 3.3% Yield
October 25, 2018 5:20 PM EDTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.57 per share, or $2.28 annualized.
The dividend will be payable on December 28, 2018, to stockholders of record on December 14, 2018, with an ex-dividend date of December 13, 2018.
The annual yield on the dividend is 3.3... More



